Please Wait.....
Report
North America Surgical Site Infection Control Market Forecast 2024-2032
Market Report I 2024-11-07 I 145 Pages I Inkwood Research
KEY FINDINGS
The North America surgical site infection control market is projected to grow with a CAGR of 4.27% over the forecast period of 2024-2032. The North America surgical site infection control market is experiencing notable growth, driven by various key factors.
MARKET INSIGHTS
The aftermath of the COVID-19 pandemic significantly increased the risk of infections among the population, heightening the probability of the spread of the novel coronavirus as well as hospital-acquired infections. This increased risk, coupled with the rising demand for various medical procedures, is expected to fuel the market's expansion as healthcare facilities prioritize infection prevention.
REGIONAL ANALYSIS
The North America surgical site infection control market growth evaluation entails a detailed assessment of the United States and Canada. Surgical site infections (SSIs) are among the costliest of all hospital-acquired infections, accounting for approximately 20% of such infections. They occur in an estimated 2% to 5% of patients undergoing inpatient surgery, with an annual incidence in the United States ranging from 160,000 to 300,000 cases. The financial burden associated with SSIs is significant, with annual costs estimated between USD 3.5 billion and USD 10 billion. Additionally, the rising number of cataract surgeries is contributing to the market's growth. In the United States alone, approximately three million cataract surgeries are performed annually, indicating a growing demand for effective infection control solutions in surgical procedures.
As the number of surgical procedures continues to rise in the United States, the prevention of SSIs has become increasingly critical. To address this, the National Healthcare Safety Network (NHSN), a web-based surveillance system managed by the Centers for Disease Control and Prevention (CDC), is utilized to track SSIs. The NHSN enables hospitals, dialysis centers, and other medical facilities to collect and report infection rates and key healthcare process measures, thereby promoting improved infection control measures. Consequently, the market for surgical site infection control solutions in the United States is experiencing growth due to the increasing emphasis on preventive measures.
On the other hand, in Canada, the healthcare system continues to face challenges in managing surgical site infections. Despite advancements in aseptic techniques, antibiotic prophylaxis, and minimally invasive surgical methods, healthcare-associated infections (HAIs) remain a significant concern, complicating recovery for many surgical patients. According to the Canadian Patient Safety Institute (CPSI), SSIs are the most common healthcare-associated infection among surgical patients, with 77% of patient deaths related to infections.
The Centers for Disease Control also notes that while there have been improvements in infection control practices, including enhanced operating room ventilation and sterilization methods, SSIs continue to be a major cause of morbidity, prolonged hospitalization, and mortality in Canada. This persistent challenge highlights the need for continued efforts in infection prevention and control, thereby influencing the growth of the surgical site infection control market in North America.
SEGMENTATION ANALYSIS
The North America surgical site infection control market segmentation includes procedure, type of infection, end-user, and product. The procedure segment is further classified into laparoscopy, orthopedic surgery, cardiovascular, obstetrics and gynecology, wound closure, plastic & reconstructive surgery, thoracic surgery, microvascular, urology, neurosurgery, and other procedures.
Laparoscopy is a minimally invasive surgical procedure used to treat diseases associated with abdominal or pelvic organs through small-sized incisions. Compared to traditional laparotomy, which requires larger incisions, laparoscopy offers significant advantages by utilizing magnified tele-images for better precision with surgical tools. Laparoscopic surgeries have gained popularity, especially in bariatric surgeries for weight reduction. The growing prevalence of obesity worldwide, coupled with an increasing preference for bariatric procedures, is driving the demand for laparoscopic surgeries. Instruments used in laparoscopy include needle drivers, trocars, bowel graspers, bipolar dissectors, biopsy forceps, laparoscopic scissors, and triangular endo-flex retractors.
Similarly, orthopedic surgery focuses on the treatment of the musculoskeletal system, addressing issues such as musculoskeletal trauma, bone degenerative diseases, sports injuries, tumors, and infections. Orthopedic surgical instruments encompass a wide range of devices, including arthroscopy devices (such as baskets, biopsy and grasping forceps, curettes, duckbill punches, hook probes, and meniscotomes), surgical drills, mallets, needle holders, retractors, Cobb elevators, Ragnell instruments, and bone tamps. The rising incidence of osteoarthritis, osteoporosis, and obesity has led to an increase in orthopedic surgeries globally, which, in turn, is driving the growth of the surgical site infection control market.
COMPETITIVE INSIGHTS
Some of the major companies operating in the North America surgical site infection control market are 3M Company, American Polyfilm, Ansell Ltd, etc.
3M Company (3M) is a diversified technology corporation with operations across multiple industries, including industrial, safety and graphics, electronics and energy, health care, and consumer markets. Headquartered in Saint Paul, Minnesota, the company maintains a global presence, serving regions such as the United States, Europe, the Middle East, and Africa (EMEA), and the Asia-Pacific.
3M's business is organized into five main segments: Industrial, Safety and Graphics, Health Care, Electronics and Energy, and Consumer. Moreover, 3M also develops and manufactures advanced technical ceramics designed for demanding applications in automotive, oil and gas, solar energy, industrial, electronics, and defense industries.
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. HIGH EMPHASIS ON ENVIRONMENTAL HYGIENE BOOSTS THE SSI CONTROL MARKET
2.5.2. DISPOSABLE AND SINGLE-USE PRODUCTS ARE SHAPING THE SURGICAL INFECTION CONTROL LANDSCAPE
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGE IN GERIATRIC POPULATION
3.1.2. INCREASED INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
3.1.3. IMPLEMENTATION OF REGULATORY GUIDELINES FOR THE PREVENTION OF HOSPITAL-ACQUIRED INFECTIONS
3.2. KEY RESTRAINTS
3.2.1. LACK OF AWARENESS ASSOCIATED WITH HOSPITAL-ACQUIRED INFECTIONS
3.2.2. SURGING MEDICAL WASTE DUE TO THE USE OF MEDICAL DISPOSABLE ITEMS
3.2.3. RISING USE OF OUTPATIENT TREATMENTS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. RISING RATE OF SURGICAL PROCEDURES
4.1.2. EXPANSION OF MINIMALLY INVASIVE AND OUTPATIENT SURGICAL PRACTICES
4.1.3. ADVANCEMENTS IN TECHNOLOGY FOR PREVENTING SURGICAL SITE INFECTIONS
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTIONS
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
5. MARKET BY PROCEDURE
5.1. LAPAROSCOPY
5.2. ORTHOPEDIC SURGERY
5.3. CARDIOVASCULAR
5.4. OBSTETRICS AND GYNECOLOGY
5.5. WOUND CLOSURE
5.6. PLASTIC & RECONSTRUCTIVE SURGERY
5.7. THORACIC SURGERY
5.8. MICROVASCULAR
5.9. UROLOGY
5.10. NEUROSURGERY
5.11. OTHER PROCEDURES
6. MARKET BY TYPE OF INFECTION
6.1. SUPERFICIAL INCISIONAL SSI
6.2. DEEP INCISIONAL SSI
6.3. ORGAN OR SPACE SSI
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS
8. MARKET BY PRODUCT
8.1. DISINFECTANTS
8.1.1. SKIN DISINFECTANTS
8.1.2. HAND DISINFECTANTS
8.2. MANUAL REPROCESSORS SOLUTIONS
8.3. SURGICAL DRAPES
8.4. SURGICAL GLOVES
8.5. SKIN PREPARATION SOLUTIONS
8.6. SURGICAL IRRIGATION
8.7. SURGICAL SCRUBS
8.8. HAIR CLIPPERS
8.9. MEDICAL NONWOVENS
8.10. OTHER PRODUCTS
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET DRIVERS
9.1.3. NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET CHALLENGES
9.1.4. KEY PLAYERS IN NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET
9.1.5. COUNTRY ANALYSIS
9.1.5.1. UNITED STATES
9.1.5.1.1. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
9.1.5.2. CANADA
9.1.5.2.1. CANADA SURGICAL SITE INFECTION CONTROL MARKET SIZE & OPPORTUNITIES
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PARTNERSHIPS & AGREEMENTS
10.1.3. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILES
10.2.1. 3M COMPANY
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCTS
10.2.1.3. STRENGTHS & CHALLENGES
10.2.2. AMERICAN POLYFILM
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCTS
10.2.2.3. STRENGTHS & CHALLENGES
10.2.3. ANSELL LTD
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCTS
10.2.3.3. STRENGTHS & CHALLENGES
10.2.4. BECTON, DICKINSON AND COMPANY (BD)
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCTS
10.2.4.3. STRENGTHS & CHALLENGES
10.2.5. BELIMED AG
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCTS
10.2.5.3. STRENGTHS & CHALLENGES
10.2.6. BIOMERIEUX SA
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCTS
10.2.6.3. STRENGTHS & CHALLENGES
10.2.7. GAMA HEALTHCARE
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCTS
10.2.7.3. STRENGTHS & CHALLENGES
10.2.8. GETINGE AB
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCTS
10.2.8.3. STRENGTHS & CHALLENGES
10.2.9. JOHNSON & JOHNSON
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCTS
10.2.9.3. STRENGTHS & CHALLENGES
10.2.10. KIMBERLY-CLARK
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. PRODUCTS
10.2.10.3. STRENGTHS & CHALLENGES
10.2.11. SOTERA HEALTH LLC
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. PRODUCTS
10.2.11.3. STRENGTHS & CHALLENGES
10.2.12. STERIS CORPORATION
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. PRODUCTS
10.2.12.3. STRENGTHS & CHALLENGES
10.2.13. STRYKER CORPORATION
10.2.13.1. COMPANY OVERVIEW
10.2.13.2. PRODUCTS
10.2.13.3. STRENGTHS & CHALLENGES
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - SURGICAL SITE INFECTION CONTROL
TABLE 2: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: KEY PLAYERS OPERATING IN NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2023
FIGURE 7: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2024-2032 (IN $ MILLION)
FIGURE 8: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 9: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 10: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2024-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 13: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 14: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 15: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 16: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2024-2032 (IN $ MILLION)
FIGURE 17: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2024-2032 (IN $ MILLION)
FIGURE 18: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY TYPE OF INFECTION, IN 2023
FIGURE 19: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 21: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2024-2032 (IN $ MILLION)
FIGURE 22: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023
FIGURE 23: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 24: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 25: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 26: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 27: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, GROWTH POTENTIAL, BY DISINFECTANTS, IN 2023
FIGURE 28: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 29: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HAND DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 30: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 31: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2024-2032 (IN $ MILLION)
FIGURE 32: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2024-2032 (IN $ MILLION)
FIGURE 33: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 34: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2024-2032 (IN $ MILLION)
FIGURE 35: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2024-2032 (IN $ MILLION)
FIGURE 36: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2024-2032 (IN $ MILLION)
FIGURE 37: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2024-2032 (IN $ MILLION)
FIGURE 38: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 39: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 40: UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
FIGURE 41: CANADA SURGICAL SITE INFECTION CONTROL MARKET, 2024-2032 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security